机构

• 上海药物研究所 [16]
• 大连化学物理研究所 [4]
• 化学研究所 [2]
• 金属研究所 [1]
• 宁波材料技术与工程研... [1]
• 上海神经科学研究所 [1]
• 更多

采集方式

• OAI收割 [35]

内容类型

• 期刊论文 [35]

发表日期

• 2025 [2]
• 2024 [2]
• 2023 [1]
• 2022 [2]
• 2021 [3]
• 2020 [1]
• 更多

学科主题

• Chemistry [3]
• Pharmacolo... [2]
• Biochemist... [1]
• Food Scien... [1]
• Neuroscien... [1]
• Spectrosco... [1]
• 更多

筛选

浏览/检索结果: 共35条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择题名升序题名降序提交时间升序提交时间降序作者升序作者降序发表日期升序发表日期降序 A patent review of BRD4 inhibitors (2020-present) 期刊论文  OAI收割 EXPERT OPINION ON THERAPEUTIC PATENTS, 2025, 页码: 16 作者:  Chen, Yanfang;  Zhou, Huanmin;  Yu, Jiamin;  Gao, Jing;  Xue, Shengyu   |  收藏  |  浏览/下载：16/0  |  提交时间：2025/04/01 BET  BRD4  inhibitor  cancer treatment  selectivity   Design, synthesis and pharmacological evaluation of 1,2,3,4-tetrahydrobenzofuro[2,3-c] pyridine derivatives as p21-activated kinase 4 inhibitors for treatment of pancreatic cancer 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2025, 卷号: 15, 期号: 1, 页码: 438-466 作者:  Li, Yang;  Fang, Yan;  Chen, Xiaoyu;  Tong, Linjiang;  Feng, Fang   |  收藏  |  浏览/下载：22/0  |  提交时间：2025/04/01 P21-activated kinase 4  Tetrahydrobenzofuro[2  3-c]pyridine  Structure-activity relationship  Allosteric inhibitor  Pharmacokinetics properties  Kinase selectivity  Pancreatic cancer  Immune infiltration   Design and synthesis of pyridazin-4-one derivatives as necroptosis inhibitors 期刊论文  OAI收割 ARCHIV DER PHARMAZIE, 2024, 页码: 16 作者:  An, Yuxiang;  Peng, Xia;  Wang, Tianchen;  Liu, Kaiyuan;  Feng, Dazhi   |  收藏  |  浏览/下载：18/0  |  提交时间：2024/12/25 inhibitor  pharmacokinetic study  pyridazin-4-one  receptor-interacting protein kinase 1  selectivity   Structure-based design of potent FABP4 inhibitors with high selectivity against FABP3 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 264, 页码: 10 作者:  Chen, Guofeng;  Xie, Hang;  Liu, Jiayuan;  Shao, Qiang;  Li, Minjun   |  收藏  |  浏览/下载：29/0  |  提交时间：2024/01/26 Methyl substitution  Selectivity  FABP4 inhibitor  Anti-inflammation  Metabolic stability   Optimization of potent, selective and orally bioavailable biphenyl scaffold as FABP4 inhibitors for anti-inflammation 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 253, 页码: 16 作者:  He, Yulong;  Li, Shunyi;  Zhu, Yueyue;  Wang, Yujie;  Chen, Yuqi   |  收藏  |  浏览/下载：92/0  |  提交时间：2023/10/17 Structure-activity relationship  FABP4 inhibitor  Biphenyl scaffold  Selectivity  Oral bioavailability  Anti-inflammation   Easily synthesized mesoporous aluminum phosphate for the enhanced adsorption performance of U(VI) from aqueous solution 期刊论文  OAI收割 JOURNAL OF HAZARDOUS MATERIALS, 2022, 卷号: 432 作者:  Wang, De;  Chen, Haiying;  Zhang, Jianfeng;  Li, Jiaxing   |  收藏  |  浏览/下载：49/0  |  提交时间：2022/12/23 Mesoporous AlPO4  Uranium-selectivity  Recyclability  Dynamic adsorption   Adjusted degradation of BRD4 S and BRD4 L based on fine structural modifications of the pyrrolopyridone scaffold 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 236, 页码: 14 作者:  Chen, Jingjing;  He, Huixin;  Wei, Aihuan;  Li, Yalei;  Cheng, Gang   |  收藏  |  浏览/下载：46/0  |  提交时间：2022/08/16 PROTAC  Pyrrolopyridone  BRD4 S  Selectivity   Study on syngas methanation over municipal solid waste char supported Ni catalyst 期刊论文  OAI收割 FUEL, 2021, 卷号: 303, 页码: 14 作者:  Luo, Jia   |  收藏  |  浏览/下载：78/0  |  提交时间：2021/10/27 MSW pyrolysis char  Syngas methanation  Ni-based catalyst  CO conversion  CH4 selectivity  CH4 yield   Discovery of 1,5-Dihydro-4H-imidazol-4-one Derivatives as Potent, Selective Antagonists of CXC Chemokine Receptor 2 期刊论文  OAI收割 ACS MEDICINAL CHEMISTRY LETTERS, 2021, 卷号: 12, 期号: 5, 页码: 836-845 作者:  Che, Jinxin;  Wang, Zhilong;  Shen, Zheyuan;  Zhuang, Weihao;  Ying, Huazhou   |  收藏  |  浏览/下载：51/0  |  提交时间：2021/08/17 cancer metastasis  CXCR1  CXCR2  selectivity  antagonist  1,5-dihydro-4H-imidazol-4-one   Divalent tranylcypromine derivative as lysine-specific demethylase 1 inhibitor 期刊论文  OAI收割 MEDICINAL CHEMISTRY RESEARCH, 2021, 页码: 8 作者:  Sun, Yin;  Li, Na;  Su, Mingbo;  Wang, Xiaowen;  Zhao, Dongmei   |  收藏  |  浏览/下载：47/0  |  提交时间：2021/05/24 Divalent tranylcypromine  LSD1 inhibitor  MV4-11 antiproliferative activity  CD86 mRNA expression  Linker  Selectivity